Skip to main content

Table 2 Characteristics per menopausal status group

From: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study

  Premenopausal Perimenopausal Naturally postmenopausal Surgically postmenopausal
n = 39,397 n = 8669 n = 14,514 n = 904
Baseline
 Age, years 36.9 ± 8.1 45.0 ± 8.1 55.3 ± 7.4 52.7 ± 8.1
 Age range, years 18–60 18–62 18–65 21-65
 Current hormonal contraception use 18,526 (47.6) 1938 (22.7) 1787 (12.6) 825 (2.6)
 Current smoker 8125 (21.0) 1969 (22.9) 2751 (19.1) 165 (18.4)
 Antihypertensive medications 1559 (4.0) 608 (7.0) 2356 (20.3) 182 (20.3)
 Lipid-lowering medications 388 (1.0) 178 (2.1) 1222 (8.4) 92 (10.2)
 Ever HT use 203 (0.5)a 275 (3.2) 1315 (9.1) 253 (28.4)
Outcome
 BMI, kg/m2 25.2 ± 4.6 26.0 ± 4.9 26.2 ± 4.5 27.3 ± 5.0
 SBP, mmHg 119 ± 13 121 ± 14 125 ± 16 126 ± 16
 DBP, mmHg 71 ± 9 72 ± 9 73 ± 9 72 ± 9
 TC, mmol/L 4.7 ± 0.8 5.0 ± 0.9 5.6 ± 1.0 5.5 ± 1.0
 LDL-c, mmol/L 2.9 ± 0.8 3.1 ± 0.8 3.6 ± 0.9 3.5 ± 0.9
 HDL-c, mmol/L 1.6 ± 0.4 1.6 ± 0.4 1.7 ± 0.4 1.6 ± 0.4
 TG, mmol/L 1.0 ± 0.5 1.0 ± 0.6 1.1 ± 0.6 1.2 ± 0.7
 Glucose, mmol/L 4.8 ± 0.6 4.9 ± 0.7 5.0 ± 0.8 5.1 ± 1.0
  1. Values given in mean ± SD or n (%)
  2. aAll reported a currently regular cycle
  3. HT hormone replacement therapy, BMI body mass index, SBP systolic blood pressure; DBP diastolic blood pressure, TC total cholesterol, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, TG triglycerides